MELAMISA
Live / Applied — Fourth extension granted (statement of use) (as of 08 Jul 2025)
What this means for you
Not registered yet, but its 22 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97558645
- Mark type
- Stylized text
- Filed
- 22 Aug 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Karen Hahn
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR BIRTH CONTROL, MENOPAUSE, ESTROGEN REPLACEMENT, OVULATION CONTROL AND OTHER GYNECOLOGICAL CONDITIONS
Owner
- Novast Laboratories, Inc., Plano, TX, US
- Novast Laboratories, Inc., Plano, TX, US
Prosecution history
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 4 GRANTED
- 08 Jul 2025 — SOU EXTENSION 4 FILED
- 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2024 — SOU EXTENSION 3 GRANTED
- 30 Dec 2024 — SOU EXTENSION 3 FILED
- 10 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2024 — SOU EXTENSION 2 GRANTED
- 10 Jul 2024 — SOU EXTENSION 2 FILED
- 10 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2024 — SOU EXTENSION 1 GRANTED
- 15 Jan 2024 — SOU EXTENSION 1 FILED